Public recall detail

Important Safety Information on ACTEMRA® (tocilizumab) - Risk of Hepatotoxicity

medium
Recall Safety notice
Quick summary

Quick summary: Important Safety Information on ACTEMRA® (tocilizumab) - Risk of Hepatotoxicity .

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: Important Safety Information on ACTEMRA® (tocilizumab) - Risk of Hepatotoxicity .

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

Brand

Issue

Serious cases of drug-induced liver injuries (DILI) have been reported in patients treated with ACTEMRA, including cases of acute liver failure requiring a transplant. There have been cases of serious liver injury reported from Canada.

Additional official information
Background{}
Companies
Audiences

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Official source Monitor products Back to recalls

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...